Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reshma Ramachandran

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
BMJ Medicine|March 20, 2023
Evidence and opportunity costs of lifestyle interventions in clinical medicineReshma Ramachandran
Healthcare Policy = Politiques De Sante|June 10, 2022
Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable AccessReshma Ramachandran
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
<b>If Left Unchecked:</b> Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna VaccineReshma Ramachandran
BMJ (Clinical Research Ed.)|October 1, 2016
Link between prescribing and gifting of educational materials should be studiedReshma Ramachandran
JAMA Network Open|April 19, 2022
FDA Indication Extrapolations-Allowing Flexibility While Providing Greater ClarityReshma Ramachandran, Joseph S Ross
JAMA|January 12, 2026
Politics, Science, and the Future of FDA Drug Regulation: FDA's Review of Mifepristone REMS as a Litmus TestReshma Ramachandran, Christopher J Morten
American Journal of Public Health|October 14, 2021
An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review VoucherReshma Ramachandran, Ravi Gupta, Jing Luo
Health Affairs (Project Hope)|July 1, 2024
Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical IngredientsMelissa Barber, Reshma Ramachandran, Suerie Moon
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 31, 2024
A Public Option for Clinical Trials? Lessons from Convalescent PlasmaVictor Roy, Joseph S Ross, Reshma Ramachandran
JAMA Internal Medicine|August 21, 2023
Medical Product Industry Ties to Patient Advocacy Organizations' Executive LeadershipShamik Bhat, Joseph S Ross, Reshma Ramachandran
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
BMJ Medicine|March 20, 2023
Evidence and opportunity costs of lifestyle interventions in clinical medicineReshma Ramachandran
Healthcare Policy = Politiques De Sante|June 10, 2022
Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable AccessReshma Ramachandran
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
<b>If Left Unchecked:</b> Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna VaccineReshma Ramachandran
BMJ (Clinical Research Ed.)|October 1, 2016
Link between prescribing and gifting of educational materials should be studiedReshma Ramachandran
JAMA Network Open|April 19, 2022
FDA Indication Extrapolations-Allowing Flexibility While Providing Greater ClarityReshma Ramachandran, Joseph S Ross
JAMA|January 12, 2026
Politics, Science, and the Future of FDA Drug Regulation: FDA's Review of Mifepristone REMS as a Litmus TestReshma Ramachandran, Christopher J Morten
American Journal of Public Health|October 14, 2021
An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review VoucherReshma Ramachandran, Ravi Gupta, Jing Luo
Health Affairs (Project Hope)|July 1, 2024
Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical IngredientsMelissa Barber, Reshma Ramachandran, Suerie Moon
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 31, 2024
A Public Option for Clinical Trials? Lessons from Convalescent PlasmaVictor Roy, Joseph S Ross, Reshma Ramachandran
JAMA Internal Medicine|August 21, 2023
Medical Product Industry Ties to Patient Advocacy Organizations' Executive LeadershipShamik Bhat, Joseph S Ross, Reshma Ramachandran
Pageof 12